| 前收市價 | 22.90 |
| 開市 | 25.35 |
| 買盤 | 20.20 |
| 賣出價 | 21.60 |
| 拍板 | 175.00 |
| 到期日 | 2024-12-20 |
| 今日波幅 | 22.90 - 25.35 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 165 |
ZacksHere's Why Insulet (PODD) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksWhy Insulet (PODD) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BenzingaWill Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
On Tuesday, Blue Orca Capital released a report on Insulet Corporation (NASDAQ:PODD), saying it is short on the insulin delivery patch pump manufacturer. The report added that Blue Orca is long on its upstart Korean competitor EOFlow Co Ltd as last week the Court of Appeals for the Federal Circuit killed a preliminary injunction that protected Insulet’s key monopoly against competition from EOFlow. The report adds that the injunction is undisclosed to investors. The report notes, “In our opinion
